KHRN:CC News and Press, Khiron Life Sciences Corp. From 01/05/23

Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products Canada NewsWire On December 30, 2022 , the Ministry of Health of Colombia reaffirmed the inclusion of plant-based medical cannabis products, i.e., Khiron products, in the mandato...

International cannabis company Khiron Life Sciences Corp.  (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC) posted a $2.6 million loss for the quarter that ended Sept. 30, primarily due to a downturn in medical marijuana sales in Colombia. Revenues were down by 24% for the q...

Khiron Life Sciences Reports Third Quarter 2022 Financial Results Canada NewsWire In Europe , revenues increased by 141% year-over-year, driven by revenues in the United Kingdom , where the Corporation is now increasing its existing product portfolio, and the specializ...

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022 Canada NewsWire TORONTO , Nov. 18, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMXC), the global leader in medic...

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom Canada NewsWire Through its newly acquired EU-GMP distribution hub in Germany , Khiron expands its product portfolio and geographic reach within Europe&#...

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference Canada NewsWire TORONTO , Sept. 13, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfur...

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California Canada NewsWire New products to be distributed through Khiron's new wholly-owned subsidiary Pharmadrug Production GmbH Khiron intro...

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022 Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMXC), the global leader in medical ...

Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), a global leader in medical cannabis throughout Europe and Latin America, today announced that Alvaro Torres, CEO and Director of the Company ...

Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic Canada NewsWire Continued Global Growth of Khiron's Proven Zerenia TM Clinic Model Focused on Patients, Physician Education and Innovation New clinic is in the district of Ipanema in ...